生物可吸收支架(BAS)的開發平台 - 開發階段，市場區隔，地區和國家，法規途徑，主要企業(2023年版)

Bioabsorbable Stents (BAS) Pipeline Report Including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update

出版日期: 2023年04月19日 | 出版商:

GlobalData | 英文 111 Pages | 訂單完成後即時交付

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

本報告提供生物可吸收支架(BAS)的開發中產品調查分析，包含各開發階段產品的比較分析，及進行中的臨床試驗相關之全面性資訊。

Abbott Vascular Inc，企業概要
- Abbott Vascular Inc，開發中產品和進行中的臨床試驗概要
Amaranth Medical Inc，企業概要
- Amaranth Medical Inc，開發中產品和進行中的臨床試驗概要
Arterius Ltd，企業概要
- Arterius Ltd，開發中產品和進行中的臨床試驗概要
Biosensors International Group Ltd，企業概要
- Biosensors International Group Ltd，開發中產品和進行中的臨床試驗概要
Biosten, LLC，企業概要
- Biosten, LLC，開發中產品和進行中的臨床試驗概要
Biotronik AG，企業概要
- Biotronik AG，開發中產品和進行中的臨床試驗概要
Biotronik SE & Co KG，企業概要
- Biotronik SE & Co KG，開發中產品和進行中的臨床試驗概要
Biotyx Medical (深圳) Co Ltd，企業概要
- Biotyx Medical (深圳) Co Ltd，開發中產品和進行中的臨床試驗概要
Boston Scientific Corp，企業概要
- Boston Scientific Corp，開發中產品和進行中的臨床試驗概要
Cardionovum GmbH，企業概要
- Cardionovum GmbH，開發中產品和進行中的臨床試驗概要
Cordis Corp，企業概要
- Cordis Corp，開發中產品和進行中的臨床試驗概要
HangZhou HuaAn Biotechnology Co., Ltd.，企業概要
- HangZhou HuaAn Biotechnology Co., Ltd.，開發中產品和進行中的臨床試驗概要
Icon Interventional Systems, Inc.，企業概要
- Icon Interventional Systems, Inc.，開發中產品和進行中的臨床試驗概要
Japan Stent Technology Co., Ltd.，企業概要
- Japan Stent Technology Co., Ltd.，開發中產品和進行中的臨床試驗概要
Kyoto Medical Planning Co Ltd，企業概要
- Kyoto Medical Planning Co Ltd，開發中產品和進行中的臨床試驗概要
Lifetech Scientific (深圳) Co Ltd，企業概要
- Lifetech Scientific (深圳) Co Ltd，開發中產品和進行中的臨床試驗概要
Manli Cardiology Ltd，企業概要
- Manli Cardiology Ltd，開發中產品和進行中的臨床試驗概要
Meril Life Sciences Pvt Ltd，企業概要
- Meril Life Sciences Pvt Ltd，開發中產品和進行中的臨床試驗概要
Micell Technologies Inc，企業概要
- Micell Technologies Inc，開發中產品和進行中的臨床試驗概要
Michigan Technological University，企業概要
- Michigan Technological University，開發中產品和進行中的臨床試驗概要
MicroPort Scientific Corp，企業概要
- MicroPort Scientific Corp，開發中產品和進行中的臨床試驗概要
Minvasys SAS，企業概要
- Minvasys SAS，開發中產品和進行中的臨床試驗概要
MIV Therapeutics Inc，企業概要
- MIV Therapeutics Inc，開發中產品和進行中的臨床試驗概要
NanoCoeur, Inc.，企業概要
- NanoCoeur, Inc.，開發中產品和進行中的臨床試驗概要
North Carolina State University，企業概要
- North Carolina State University，開發中產品和進行中的臨床試驗概要
Northwestern University，企業概要
- Northwestern University，開發中產品和進行中的臨床試驗概要
OrbusNeich，企業概要
- OrbusNeich，開發中產品和進行中的臨床試驗概要
Pediastent LLC，企業概要
- Pediastent LLC，開發中產品和進行中的臨床試驗概要
QualiMed Innovative Medizinprodukte GmbH，企業概要
- QualiMed Innovative Medizinprodukte GmbH，開發中產品和進行中的臨床試驗概要
REVA Medical Inc，企業概要
- REVA Medical Inc，開發中產品和進行中的臨床試驗概要
S3v Vascular Technologies，企業概要
- S3v Vascular Technologies，開發中產品和進行中的臨床試驗概要
Shanghai Bio-heart Biological Technology Co Ltd，企業概要
- Shanghai Bio-heart Biological Technology Co Ltd，開發中產品和進行中的臨床試驗概要
Shanghai Healing Medical Instruments Co Ltd，企業概要
- Shanghai Healing Medical Instruments Co Ltd，開發中產品和進行中的臨床試驗概要
Tepha Inc，企業概要
- Tepha Inc，開發中產品和進行中的臨床試驗概要
Tremedics Medical Devices LLC，企業概要
- Tremedics Medical Devices LLC，開發中產品和進行中的臨床試驗概要
UAB Minority Health and Health Equity Research Center，企業概要
- UAB Minority Health and Health Equity Research Center，開發中產品和進行中的臨床試驗概要
University of Florida，企業概要
- University of Florida，開發中產品和進行中的臨床試驗概要
University of Strathclyde，企業概要
- University of Strathclyde，開發中產品和進行中的臨床試驗概要
VasoTech Inc.，企業概要
- VasoTech Inc.，開發中產品和進行中的臨床試驗概要
Xenogenics Corporation，企業概要
- Xenogenics Corporation，開發中產品和進行中的臨床試驗概要

第6章生物可吸收支架(BAS) - 最近的開發

第7章附錄

簡介目錄

Product Code: GDME1519EPD

Abstract

GlobalData's Medical Devices sector report, "Bioabsorbable Stents (BAS) Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update" provides comprehensive information about the Bioabsorbable Stents (BAS) pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Bioabsorbable stents are also known as bioreabsorbable or biodegradable coronary stents. The advantage of this stent is that it does not leave any metal body behind and hence, the possibility of late-stent thrombosis and restenosis decreases. Bioabsorbable stents help in better drug delivery compared to metallic stents.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

Extensive coverage of the Bioabsorbable Stents (BAS) under development
The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
The report reviews the major players involved in the development of Bioabsorbable Stents (BAS) and list all their pipeline projects
The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
The report provides key clinical trial data of ongoing trials specific to pipeline products
Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

Formulate significant competitor information, analysis, and insights to improve R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
Identify and understand important and diverse types of Bioabsorbable Stents (BAS) under development
Develop market-entry and market expansion strategies
Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
In-depth analysis of the product's current stage of development, territory and estimated launch date

1 Table of Contents

1.1 List of Tables
1.2 List of Figures

2 Introduction

2.1 Bioabsorbable Stents (BAS) Overview

3 Products under Development

3.1 Bioabsorbable Stents (BAS) - Pipeline Products by Stage of Development
3.2 Bioabsorbable Stents (BAS) - Pipeline Products by Territory
3.3 Bioabsorbable Stents (BAS) - Pipeline Products by Regulatory Path
3.4 Bioabsorbable Stents (BAS) - Pipeline Products by Estimated Approval Date
3.5 Bioabsorbable Stents (BAS) - Ongoing Clinical Trials

4 Bioabsorbable Stents (BAS) - Pipeline Products under Development by Companies

4.1 Bioabsorbable Stents (BAS) Companies - Pipeline Products by Stage of Development
4.2 Bioabsorbable Stents (BAS) - Pipeline Products by Stage of Development

5 Bioabsorbable Stents (BAS) Companies and Product Overview

5.1 Abbott Vascular Inc Company Overview
- 5.1.1 Abbott Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview
5.2 Amaranth Medical Inc Company Overview
- 5.2.1 Amaranth Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
5.3 Arterius Ltd Company Overview
- 5.3.1 Arterius Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.4 Biosensors International Group Ltd Company Overview
- 5.4.1 Biosensors International Group Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.5 Biosten, LLC Company Overview
- 5.5.1 Biosten, LLC Pipeline Products & Ongoing Clinical Trials Overview
5.6 Biotronik AG Company Overview
- 5.6.1 Biotronik AG Pipeline Products & Ongoing Clinical Trials Overview
5.7 Biotronik SE & Co KG Company Overview
- 5.7.1 Biotronik SE & Co KG Pipeline Products & Ongoing Clinical Trials Overview
5.8 Biotyx Medical (Shenzhen) Co Ltd Company Overview
- 5.8.1 Biotyx Medical (Shenzhen) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.9 Boston Scientific Corp Company Overview
- 5.9.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
5.10 Cardionovum GmbH Company Overview
- 5.10.1 Cardionovum GmbH Pipeline Products & Ongoing Clinical Trials Overview
5.11 Cordis Corp Company Overview
- 5.11.1 Cordis Corp Pipeline Products & Ongoing Clinical Trials Overview
5.12 HangZhou HuaAn Biotechnology Co., Ltd. Company Overview
- 5.12.1 HangZhou HuaAn Biotechnology Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview
5.13 Icon Interventional Systems, Inc. Company Overview
- 5.13.1 Icon Interventional Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.14 Japan Stent Technology Co., Ltd. Company Overview
- 5.14.1 Japan Stent Technology Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview
5.15 Kyoto Medical Planning Co Ltd Company Overview
- 5.15.1 Kyoto Medical Planning Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.16 Lifetech Scientific (Shenzhen) Co Ltd Company Overview
- 5.16.1 Lifetech Scientific (Shenzhen) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.17 Manli Cardiology Ltd Company Overview
- 5.17.1 Manli Cardiology Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.18 Meril Life Sciences Pvt Ltd Company Overview
- 5.18.1 Meril Life Sciences Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.19 Micell Technologies Inc Company Overview
- 5.19.1 Micell Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
5.20 Michigan Technological University Company Overview
- 5.20.1 Michigan Technological University Pipeline Products & Ongoing Clinical Trials Overview
5.21 MicroPort Scientific Corp Company Overview
- 5.21.1 MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
5.22 Minvasys SAS Company Overview
- 5.22.1 Minvasys SAS Pipeline Products & Ongoing Clinical Trials Overview
5.23 MIV Therapeutics Inc Company Overview
- 5.23.1 MIV Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.24 NanoCoeur, Inc. Company Overview
- 5.24.1 NanoCoeur, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.25 North Carolina State University Company Overview
- 5.25.1 North Carolina State University Pipeline Products & Ongoing Clinical Trials Overview
5.26 Northwestern University Company Overview
- 5.26.1 Northwestern University Pipeline Products & Ongoing Clinical Trials Overview
5.27 OrbusNeich Company Overview
- 5.27.1 OrbusNeich Pipeline Products & Ongoing Clinical Trials Overview
5.28 Pediastent LLC Company Overview
- 5.28.1 Pediastent LLC Pipeline Products & Ongoing Clinical Trials Overview
5.29 QualiMed Innovative Medizinprodukte GmbH Company Overview
- 5.29.1 QualiMed Innovative Medizinprodukte GmbH Pipeline Products & Ongoing Clinical Trials Overview
5.30 REVA Medical Inc Company Overview
- 5.30.1 REVA Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
5.31 S3V Vascular Technologies Company Overview
- 5.31.1 S3V Vascular Technologies Pipeline Products & Ongoing Clinical Trials Overview
5.32 Shanghai Bio-heart Biological Technology Co Ltd Company Overview
- 5.32.1 Shanghai Bio-heart Biological Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.33 Shanghai Healing Medical Instruments Co Ltd Company Overview
- 5.33.1 Shanghai Healing Medical Instruments Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.34 Tepha Inc Company Overview
- 5.34.1 Tepha Inc Pipeline Products & Ongoing Clinical Trials Overview
5.35 Tremedics Medical Devices LLC Company Overview
- 5.35.1 Tremedics Medical Devices LLC Pipeline Products & Ongoing Clinical Trials Overview
5.36 UAB Minority Health and Health Equity Research Center Company Overview
- 5.36.1 UAB Minority Health and Health Equity Research Center Pipeline Products & Ongoing Clinical Trials Overview
5.37 University of Florida Company Overview
- 5.37.1 University of Florida Pipeline Products & Ongoing Clinical Trials Overview
5.38 University of Strathclyde Company Overview
- 5.38.1 University of Strathclyde Pipeline Products & Ongoing Clinical Trials Overview
5.39 VasoTech Inc. Company Overview
- 5.39.1 VasoTech Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.40 Xenogenics Corporation Company Overview
- 5.40.1 Xenogenics Corporation Pipeline Products & Ongoing Clinical Trials Overview

6 Bioabsorbable Stents (BAS)- Recent Developments

6.1 Mar 08, 2023: OrbusNeich Announces Record Revenue of US$136.8 Million, Adjusted Net Profit Up 25% to US$26.7 Million
6.2 Feb 09, 2023: Terumo Notice Concerning Revision of the Full-Year Financial Guidance for Fiscal Year Ending March 31, 2023
6.3 Feb 09, 2023: Terumo Corp Announces Consolidated Financial Results for the Third Quarter Ended December 31, 2022
6.4 Nov 10, 2022: Terumo Corp Announces Consolidated Financial Results for the Second Quarter Ended September 30, 2022
6.5 Aug 16, 2022: Boston Scientific Announces Upcoming Conference Schedule
6.6 Apr 28, 2022: Boston Scientific reports net sales of $3.03bn in Q1 2022
6.7 Apr 27, 2022: Boston Scientific Announces Results for First Quarter 2022